Sen. Sanders Issues Statement on Eli Lilly Decision to Lower Starter Price of Blockbuster Weight-Loss Drug Zepbound
August 28, 2024
August 28, 2024
BURLINGTON, Vermont, Aug. 28 -- Sen. Bernie Sanders, I-Vermont, issued the following statement on Aug. 27, 2024:
* * *
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), on Tuesday issued the following statement after drugmaker Eli Lilly agreed to significantly lower the list price for the starter dose of its weight loss drug Zepbound:
Last month, President Biden and I co-authored an op-ed demandi . . .
* * *
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), on Tuesday issued the following statement after drugmaker Eli Lilly agreed to significantly lower the list price for the starter dose of its weight loss drug Zepbound:
Last month, President Biden and I co-authored an op-ed demandi . . .